Vice President, mRNA CDMO

Danaher Corporation•Boston, MA

10d•$240,000 - $300,000•Remote

About The Position

Bring more to life. Are you ready to accelerate your potential and make a real difference within life sciences, diagnostics and biotechnology? At Aldevron, one of Danaher’s 15+ operating companies, our work saves lives—and we’re all united by a shared commitment to innovate for tangible impact. You’ll thrive in a culture of belonging where you and your unique viewpoint matter. And by harnessing Danaher’s system of continuous improvement, you help turn ideas into impact – innovating at the speed of life. At Aldevron, we deliver world-class CDMO services that accelerate the development of groundbreaking therapies. Our mission is to be the engine of innovation for genomic medicine pioneers. As a member of our team, you’ll help bring life-changing innovations to life—impacting millions around the world. We bring together deep scientific expertise, an unwavering commitment to quality, and a collaborative spirit to drive progress. Whether you're launching your career or bringing years of experience, we value the unique perspective you bring. Join us and become part of a mission-driven team advancing science and unlocking human potential—one discovery at a time.

Requirements

Bachelor’s degree in Life Sciences, Business, or a related field required; MBA or advanced degree preferred.
13+ years of experience in product management, strategic marketing, commercial leadership, business strategy, or general management within life sciences, bioprocessing, genomic medicine, CDMO, mRNA, nucleic acids, biologics, or related markets.
Demonstrated experience leading managers and senior professionals in a complex, matrixed business environment.
Proven ability to develop and execute portfolio strategy, product lifecycle management, market-back planning, and cross-functional governance processes.
Strong business and commercial acumen with experience driving revenue growth, profitability, customer value, and competitive differentiation.
Track record of influencing senior stakeholders and leading strategic decision making across Commercial, R&D, Operations, Finance, Quality, Regulatory, and other cross-functional teams.
Experience resolving complex business challenges that require balancing customer, technical, operational, regulatory, financial, and commercial considerations; FDA-regulated industry experience preferred.

Nice To Haves

Direct experience leading mRNA, genomic medicine, cell and gene therapy, biologics, or advanced therapeutics portfolios in a CDMO, biotech, or life sciences environment.
Prior Sr. level accountability with demonstrated success driving business growth, profitability, and strategic investment decisions.
Experience leading global commercial expansion, portfolio transformation, acquisitions/integrations, or new market entry initiatives within a highly regulated industry.

Responsibilities

Define and execute the strategic direction for the mRNA portfolio, with accountability for growth, profitability, portfolio performance, and long-term business outcomes.
Establish portfolio priorities, investment decisions, pricing strategies, and lifecycle plans that align customer needs, market opportunities, and business objectives.
Translate customer insights, competitive intelligence, emerging technologies, and industry trends into differentiated value propositions and future portfolio roadmaps.
Build, coach, and develop a high-performing product management team through managers and senior leaders, ensuring strong talent, succession planning, and organizational capability.
Establish governance processes that connect product strategy to operating plans, revenue growth, margin improvement, innovation priorities, and operational readiness.
Partner with Commercial, R&D, Operations, Finance, Quality, Regulatory, and Strategy leaders to align resources, investments, capacity plans, and execution priorities.
Serve as the executive spokesperson for the mRNA portfolio, influencing senior stakeholders, leading strategic decision making, and engaging key customers and industry partners.